3 Results 3.1 Patient samples The hypothyroidism sample (N = 40) included the following co-occurring diagnoses and conditions (N = 21) made at least 1 year before starting L-carnitine supplementation in the study: hypertension (N = 6), type 2 diabetes (N = 6), sleep apnea managed with CPAP treatment (N = 3), Sjgrens Syndrome (N = 2), vitiligo (N = 2), hypercholesteremia (N = 2), menopausal symptoms (N = 2), asthma (N = 1), celiac sprue (N =1), and Menieres Disease (N = 1)
These claims form a central part of the ongoing litigation involving GLP-1 drugs
Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials
CAROLYN BRAMANTE: Well, I think there's no thought that older adults are the only individuals who will benefit
demonstrated that a 5.6% weight loss in the group treated with liraglutide 1.8 mg/day compared with placebo was associated to reductions in both total fat and lean body mass measured by Dual-Energy X-ray Absorptiometry (DXA), as well as in visceral and subcutaneous adipose tissues measured by Magnetic Resonance Imaging (MRI) [54]